Dartmouth Middle Meningeal Embolization Trial (DaMMET)
NCT04270955 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2024-02-22
Summary
Chronic subdural hematomas (cSDH) are one form of bleeding in the head. They are one of the most common diseases encountered by neurosurgeons across the country. The cSDH can push on the brain and produce symptoms that include seizures, weakness, loss of sensation, and confusion. Many of these cSDH produce repetitive bleeding.
Treatment has largely consisted of surgical drainage of hematoma (also known as a blood clot) through either a small hole in the skull or open surgery. However, it is common for the cSDH to reappear despite these procedures. A recent study has shown a treatment failure rate of 27% and a need for additional surgery at 19%.
A new approach to treatment of cSDH blocks the blood supply to the tissue that produces the repeated bleeding. Catheters are used to gain access to the middle meningeal artery (MMA), an artery that supplies the coverings of the brain. The artery is blocked using small particles or glue in a process called embolization. A recent pilot study of 72 patients who underwent MMA embolization showed a much lower rate of repeated bleeding. Based on these results, it is thought that this procedure holds promise in reducing the number of cSDH that require one or more operations. The goal of this study is to systematically examine if blocking the blood supply to the tissue responsible for repeated bleeding helps the cSDH resolve and improves patient outcomes.
Conditions
- Chronic Subdural Hematoma
- Subdural Hematoma
Interventions
- PROCEDURE
-
Embolization of the Middle Meningeal Artery
Using established endovascular techniques and materials patient will have a diagnostic catheter based angiogram performed on the side(s) of the brain where the subdural hematoma is present. After verifying the vascular anatomy to ensure safety of the procedure the Middle Meningeal Artery will be embolized.
- PROCEDURE
-
Standard of care including possible surgical evacuation of subdural hematoma
Standard of care could include observation or intervention including surgical drainage of subdural hematoma by bedside drain, Subdural Evacuating Port System (SEPS), burr hole or craniotomy
Sponsors & Collaborators
-
Dartmouth-Hitchcock Medical Center
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-11
- Primary Completion
- 2024-01-11
- Completion
- 2024-01-11
Countries
- United States
Study Locations
More Related Trials
-
Scandinavian Multicentre Acute Subdural Hematoma (SMASH) Study
NCT03284190 ·Status: UNKNOWN
-
Bedside Versus Operating Room Burr-Hole Drainage of Chronic Subdural Hematoma (DECIDE)
NCT03053895 ·Status: UNKNOWN ·Phase: NA
-
Minimally Invasive Intracranial Hematoma Aspiration for Spontaneous Intracerebral Hemorrhage
NCT06429553 ·Status: RECRUITING ·Phase: NA
-
Radiological Changes of Glymphatic-meningeal Lymphatic Drainage System After Subarachnoid Hemorrhage
NCT06444438 ·Status: RECRUITING
-
A Clinical Registry of Spontaneous Intracranial Hypotension
NCT05922514 ·Status: RECRUITING
-
MIS Hematoma Evacuation
NCT04466553 ·Status: WITHDRAWN
-
Multimodal Monitoring in Patients With Spontaneous Intracerebral Hemorrhage
NCT02326571 ·Status: COMPLETED
-
The "Concussion or Brain Bleed" Trial
NCT04002505 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Tranexamic Acid in the Treatment of Residual Chronic Subdural Hematoma -2
NCT04898712 ·Status: UNKNOWN ·Phase: PHASE2
-
Neuroinflammatory Response and Headache Control in Patients After Subarachnoid Hemorrhage
NCT03604276 ·Status: ACTIVE_NOT_RECRUITING
-
Decompressive Hemicraniectomy in Intracerebral Hemorrhage
NCT02258919 ·Status: COMPLETED ·Phase: NA
-
Chronic Subdural Hematoma and Aspirin
NCT03120182 ·Status: COMPLETED ·Phase: NA
-
Role of Dexamethasone in the Conservative Treatment of Chronic Subdural Hematoma
NCT02362321 ·Status: TERMINATED ·Phase: PHASE4
-
Dexamethasone Versus Burr Hole Craniostomy for Symptomatic Chronic Subdural Hematoma
NCT02111785 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
To Scan or Not to Scan: The Role of Follow-up CT Scanning for Management of Chronic Subdural Hematoma After Neurosurgical Evacuation
NCT01624545 ·Status: COMPLETED ·Phase: NA
-
Pathophysiology and Treatment of Cerebrospinal Hypotension Exploration Study
NCT06805591 ·Status: ENROLLING_BY_INVITATION
-
Mgt of Chronic Subdural Hematoma Using Dexamethasone
NCT02938468 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Tranexamic Acid in Chronic Subdural Hematomas
NCT02568124 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effect of Different Intravenous Fluids on Post-operative Chronic Subdural Hematoma Size and Recurrence
NCT03831997 ·Status: UNKNOWN
-
Interest of Oral Corticosteroids in the Treatment of Chronic Subdural Hematomas
NCT01380028 ·Status: TERMINATED ·Phase: PHASE3
-
Ventriculostomies in SAH: ICP Open or Not?
NCT00787020 ·Status: COMPLETED
-
Targeting Spreading Depolarization After Chronic Subdural Hematoma Surgery (TASD)
NCT04966546 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Lumbar Drain vs Extraventricular Drain to Prevent Vasospasm in Subarachnoid Hemorrhage
NCT03065231 ·Status: RECRUITING ·Phase: NA
-
Aneurysms and Carotid Artery Block in Newborns
NCT00646672 ·Status: COMPLETED
-
HEMOglobin Transfusion Threshold in Traumatic Brain Injury OptimizatioN: The HEMOTION Trial
NCT03260478 ·Status: COMPLETED ·Phase: NA